Alterity Therapeutics Limited | PRAN - Ebitda


Alterity Therapeutics Limited reported AUD-7.72M in EBITDA for its fiscal semester ending in June of 2023.





Ebitda Change Date
Alterity Therapeutics Limited AUD -7.72M 2.99M Jun/2023
Arca Biopharma USD -25.07M 5.23M Mar/2025
aTyr Pharma USD -26.58M 26.32M Sep/2025
Brainstorm Cell Therapeutics USD -3.04M 99K Mar/2025
Capricor Therapeutics USD -24.58M 17.26M Mar/2025
Cara Therapeutics USD -2.39M 3.16M Mar/2025
CSL USD 1.96B 1.27B Jun/2025
Esperion Therapeutics USD -27.51M 9.5M Sep/2023
Immunic USD -22.78M 753K Jun/2024
Insmed USD -297.13M 71.11M Jun/2025
Minerva Neurosciences USD -4.36M 1.71M Sep/2024
TherapeuticsMD USD -1.64M 700K Sep/2023